Akari Therapeutics Receives FDA Fast Track Designation for Nomacopan for Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)

August 14, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search